Company Description
For FY2025, BFHIV reported revenue of $3.8B with net income of $518.0M and diluted earnings per share of $10.89. The company operates at a net profit margin of 13.5%.
This page collects what Stock Titan holds for BFHIV, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
BFHIV Metrics & Rankings
Latest News
SEC Filings
BFHIV has filed 5 recent SEC filings, including 2 Form 4, 2 Form 144, 1 Form 8-K. The most recent filing was submitted on June 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BFHIV SEC filings →
Financial Highlights
BFHIV generated $3.8B in revenue in FY2025, and net income was $518.0M, reflecting a 13.5% net profit margin. Diluted earnings per share stood at $10.89. The company generated $2.1B in operating cash flow.